IP Library Granted Patent US 10,930,367
Granted Patent B2
US 10,930,367 · App. 14/738,483 · Granted Feb 23, 2021

Methods, models, systems, and apparatus for identifying target sequences for Cas enzymes or CRISPR-Cas systems for target sequences and conveying results thereof

Inventors: Feng Zhang (Cambridge, MA); Yinqing Li (Cambridge, MA); David Arthur Scott (Cambridge, MA); Joshua Asher Weinstein (Cambridge, MA); Patrick Hsu (Cambridge, MA)
Assignees: THE BROAD INSTITUTE, INC.; MASSACHUSETTS INSTITUTE OF TECHNOLOGY; PRESIDENT AND FELLOWS OF HARVARD COLLEGE
G16B20/00C12N9/22C12N15/1089C12N15/113C12N15/1082C12N2310/20C12N2320/11
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,930,367
App. No.
14/738,483
Granted
Feb 23, 2021
Kind
B2
Abstract

Disclosed are thermodynamic and multiplication methods concerning CRISPR-Cas systems, and apparatus therefor.

Claims (53)

1. A method for selecting and producing an engineered CRISPR complex for targeting and/or cleavage of a candidate target nucleic acid sequence within a eukaryotic cell, comprising the steps of:

(a) determining amount, location and nature of mismatch(es) of guide sequence of potential CRISPR complex(es) and the candidate target nucleic acid sequence,

(b) determining contribution of each of the amount, location and nature of mismatch(es) to hybridization free energy of binding between the target nucleic acid sequence and the guide sequence of potential CRISPR complex(es) from a training data set,

(c) based on the contribution analysis of step (b), predicting cleavage at the location(s) of the mismatch(es) of the target nucleic acid sequence by the potential CRISPR complex(es),

(d) selecting the CRISPR complex from potential CRISPR complex(es) based on whether the prediction of step (c) indicates that it is more likely than not that cleavage will occur at location(s) of mismatch(es) by the CRISPR complex;

(e) producing the selected CRISPR complex or nucleic acid molecule(s) encoding the selected CRISPR complex for targeting and/or cleavage of the candidate target nucleic acid sequence within the eukaryotic cell; and

(f) delivering the selected CRISPR complex or nucleic acid molecule(s) encoding the selected CRISPR complex into the eukaryotic cell, wherein the selected CRISPR complex targets and/or cleaves the candidate target nucleic acid sequence within the eukaryotic cell.

2. The method of claim 1 wherein the candidate target sequence is a DNA sequence, and the mismatch(es) are of RNA of potential CRISPR complex(es) and the DNA.

3. The method of claim 1 , wherein step (b) is performed by

determining known local free energies, ΔGij(k), between every guide RNA sequence i and target DNA nucleic acid sequence j at position k,

calculating values of the effective free-energy Z ij using the relationship p ij ∝e −βZij ,where p ij is measured cutting frequency by guide RNA sequence i on target DNA nucleic acid sequence j in the training set and β is a positive constant of proportionality,

determining the weights which are position-dependent weights α k by fitting the known value of ΔGij(k) and the calculated value of Z ij across each guide RNA/target DNA sequence pair in the training set in the sum across all N bases of the guide-sequence

Z

ij

=

k

=

1

N

α

k

Δ

G

ij

(

k

)

by writing the above equation in the matrix form {right arrow over (Z)}=G{right arrow over (α)}

and wherein, step (c) is performed by

estimating the effective free-energy Zest using the determined position dependent weights in the equation

{right arrow over (Z est )}=G {right arrow over (α)}

and determining estimated spacer-target cutting frequencies p est αe −βZest , to thereby predict cleavage.

4. The method of claim 2 wherein the distance, in bp, between the first and last base of the target sequence is 18.

5. The method of claim 1 wherein predicting cleavage comprises predicting whether cleavage is more likely than not to occur at location(s) of mismatch(es), and thereby predicting cleavage.

6. The method of claim 1 , further comprising normalizing the calculated values of the effective free energy of hybridization Z for each guide RNA/target DNA sequence pair in the training set.

7. The method of claim 1 , further comprising filtering out calculated value of the effective free energy of hybridization Z for each guide RNA/target DNA sequence pair in the training set which have a sequencing depth which is below a minimum sequencing depth.

8. The method of claim 1 , wherein the method is implemented by a computer system comprising:

a. a memory unit configured to receive and/or store sequence information of the candidate target nucleic acid sequence; and

b. one or more processors alone or in combination programmed to perform steps (a) to (d).

9. The method of claim 1 , wherein step (b) is performed by:

defining a thermodynamic model having a set of weights linking effective free energy of hybridization Z to local free energies G;

defining a training set of the guide sequence/target DNA sequence pairs;

inputting known values of local free energies G for each guide sequence/target DNA sequence pair in the training set;

calculating a value of effective free energy of hybridization Z for each guide sequence/target DNA sequence pair in the training set;

determining the weights using a machine learning algorithm, and

outputting the weights whereby the weights can be used to estimate the free energy of hybridization for any sequence.

10. The method of claim 1 wherein the guide sequence is comprised within a single guide RNA (sgRNA) or within a CRISPR-Cas system chimera RNA (chiRNA).

11. The method of claim 1 , wherein the selected CRISPR complex generates a cleavage within the candidate target nucleic acid sequence within the eukaryotic cell.

Assignments (5)
CONFIRMATORY LICENSE Recorded Oct 15, 2015
From: BROAD INSTITUTE, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036872/0885 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2015
From: ZHANG, FENG
To: THE BROAD INSTITUTE INC.; MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 036794/0325 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2015
From: LI, YINQING; SCOTT, DAVID ARTHUR
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 036794/0383 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2015
From: WEINSTEIN, JOSHUA ASHER
To: THE BROAD INSTITUTE INC.
Reel/Frame 036794/0412 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2015
From: HSU, PATRICK
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 036794/0448 →
Continuity (14)
Continuation In Part PCTUS2013074812 · Dec 12, 2013
Provisional Application 61836080 · Jun 17, 2013
Provisional Application 61758468 · Jan 30, 2013
Provisional Application 61769046 · Feb 25, 2013
Provisional Application 61802174 · Mar 15, 2013
Provisional Application 61806375 · Mar 28, 2013
Provisional Application 61814263 · Apr 20, 2013
Provisional Application 61819803 · May 6, 2013
Provisional Application 61828130 · May 28, 2013
Provisional Application 61736527 · Dec 12, 2012
Provisional Application 61748427 · Jan 2, 2013
Provisional Application 61791409 · Mar 15, 2013
Provisional Application 61835931 · Jun 17, 2013
Related Publication 20150356239A1 · Dec 10, 2015
Cited By (35)
US 12,201,699 US 12,215,343 US 12,215,365 US 12,251,429 US 12,251,450 US 12,252,707 US 12,258,595 US 12,281,303 US 12,281,338 US 12,344,869 US 12,351,837 US 12,359,218 US 12,390,514 US 12,398,406 US 12,406,749 US 12,410,435 US 12,421,506 US 12,435,320 US 12,435,330 US 12,435,331 US 12,441,995 US 12,454,687 US 12,473,543 US 12,473,573 US 12,509,680 US 12,516,308 US 12,522,807 US 12,553,065 US 12,559,737 US 12,570,972 US 12,571,005 US 12,584,118 US 12,624,353 US 12,624,354 US 12,668,815